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SIX TESTS FOR CARCINOGENICITY
APPENDIX III
MAMMALIAN CELL TRANSFORMATION IN VITRO
J. A. STYLES
TRANSFORMATION ofmammalian cells in
tissue culture by chemical carcinogens has
been studied by many investigators, and
reviewed by Di Paolo (1974 a, b) Heidel-
berger (1973 a, b; 1975) and Mishra and
Di Mayorca (1974). As a result of these
investigations the use of in vitro trans-
formation as a rapid test to detect
carcinogenic chemicals has been proposed.
Di Mayorca et al. (1973) and Mishra and
Di Mayorca (1974) have proposed the use
of standardized cell lines, short exposure
to the chemical being tested, and plating
in softagartoassess malignanttransforma-
tion. Plating efficiency oftreated cells was
assayed in liquid culture so that the trans-
formation frequency could be calculated.
This method has been modified (Styles,
1977) to include metabolic activation of
the test compound by rat liver postmito-
chondrial supernatant (Ames et al., 1975).
MATERIALS AND METHODS
The method used was that described by
Styles (1977).
Cells.-The cells used separately in this
study were: Wi-38 (human lung), Chang
(human liver) and BHK-21 C13 (baby Syrian
hamster kidney) were used to test compounds.
BHK-21 PyY (polyoma virus transformed
BHK-21 C13 cells) and HeLa (humantumour)
were used to check agar. W1-38 cells were
used to test 107 compounds, and Chang were
used to test 17 compounds, including 4
previously tested with W1-38. BHK-21 were
used to test 120 compounds. The cells were
obtained from Flow Laboratories Ltd, Irvine,
Scotland and Gibco Biocult Ltd, Paisley,
Scotland.
Compound solutions.-Compounds used in
the assay were dissolved in DMSO or water
to give solutions of the following concentra-
tions: 25, 5, 1, 0-2, 0 04, 0-008 mg/ml. The
volume ofstock solution added to 1 ml of cell
suspension was 10 ,ul, to give the following
concentrations: 250, 50, 10, 2, 0 4, 0.08 jug/ml and a concentration of solvent of 1% v/v
Replicate cell suspensions were dosed with
each concentration of compound.
RESULTS
A summary of the results of assays
carried out on 120 chemicals with and
without S9 mix is given in Table 111.1.
The spontaneous transformation fre-
quencies for the 3 cell types are given in
Table III.2. The threshold levels for trans-
formation frequency indicating a positive
result in the test are as follows:
BHK-21
W1-38
Chang
Transformation frequency per
106 survivors
Regarded as
Spontaneous positive induction
50 250
5 245
8 40
If the spontaneous transformation fre-
quency of BHK cells increases to levels in
excess of 50 per 106 cells plated in agar,
cells may be cloned in liquid medium to
select lines which give lower transforma-
tion frequencies in agar (Bouck and Di
Mayorca, 1976).
A comparison between false results
given by theAmestestand celltransforma-
tion is given in TableVIofthemainpaper.
This test has been able to distinguish
between a number of related carcinogen
and non-carcinogen pairs (Fig. 5 and 6).
DISCUSSION
The cell transformation assay was, with
the selection of compounds tested, and the
use of 2 cell lines, 94% accurate in
determining carcinogenic or non-carcino-
genic activity. Of 120 compounds tested,
only 11 were detected by one cell type
alone; furthermore, if one cell type only is
considered, the predictive figures are only
slightly reduced (88% for W1-38 and
Chang, 91% for BHK 21). These results
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Compound
Acridine
2-Acetylaminofluorene
4-Acetylaminofluorene
Aflatoxin B
4-Aminoazobenzene
2-Aminobiphenyl
4-Aminobiphenyl
2-Aminochrysene
6-Aminochrysene
3-Aminopyrene
2-Aminonaphthalene-1-sulphonic
acid
Aniline
p-Anisidine
Anthracene
2-Aminoanthracene
Anthranilic acid
Anthraquinone
Anthrone
1,2-Benzanthracene
Benzathrone
Benzidine
Benzimidazole
Benzoic acid
3,4-Benzpyrene
6-Benzoyl-2-naphthol
Biphenyl
Bis azo compound
Bis(Chloromethyl)ether
N,N'-Bis(2-naphthyl)-p-
phenylenediamine
Butanesultone
Caffeine
Calmagite
Camphor
Carbazole
Chlorambucil
Chloramine T
Cholesterol
Colchicine
Croton oil
Cyanocobalamin (B12)
Cycasin acetate
Cyclohexylamine
Cyclophosphamide
3,3'-Diaminobenzidine
2,7-Diaminofluorene
3,4,5,6-Dibenzacridine
1,2,3,4-Dibenzanthracene
3,4,9,10-Dibenzpyrene
3,3'-Dichlorobenzidine
2,4-Dichlorophenoxyacetate
Dicyclohexylamine
D.D.T.
Dieldrin
Diethylnitrosamine
Diethylstilboestrol
3,3'-Dimethoxybenzidine
4-Dimethylaminoazobenzene
9,10-Dimeuthylanthracene
TABLE 111.1
Transformation frequency per 106 survivors at LC5o
ofcompound
Human Rodent
W1-38 Chang BHK-21 Carcinogenicity
A A A
S9+ S9- S9+ S9- S9+ S9- Test Lit.
6 5 33 36 - --
48 8 260 83 + +
18 15 95 106 - -
52 8 652 74 + +
40 7 286 43 + +
44 7 260 46 + +
4 6 328 45 + +
5 6 354 58 + +
6 7 740 68 + +
54 5 41 48 + +
10 6 80 43 - -
5 4 50 43 - -
6 4 46 40 - -
7 6 50 41 - -
23 8 276 66 + +
6 5 48 44 - -
11 13 56 39 - -
6 6 47 55 - -
54 9 360 72 + +
10 12 48 38 - -
66 8 390 61 + +
6 8 46 56 - -
5 5 46 49 - -
71 11 642 95 + +
8 5 358 83 + -
9 13 39 44 - -
8 4 81 112 - -
56 10 332 64 + +
9 13 51 42 - -
51 64 328 396 + +
5 7 39 36 - -
8 8 44 37 - -
5 6 49 42 - -
6 6 47 39 - _
6 8 363 72 + +
7 7 37 51 - -
7 9 41 46 - -
8 4 36 43 - -
9 10 70 67 - +
5 5 45 38 - -
62 8 482 45 + +
7 9 33 35 - -
26 6 488 60 + +
8 8 14 10 220 144 - -
8 10 294 171 + +
10 9 192 82 - +
34 5 90 34 + +
78 10 309 53 + +
54 7 287 42 + +
4 4 48 54 - -
5 6 9 11 52 51 - -
7 5 56 47 - -
8 5 48 36 - -
53 18 644 258 + +
10 6 11 12 42 50 - +
64 6 324 63 + +
52 6 120 134 + +
28 7 422 53 + +
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TABLE III.1-continued.
Transformation frequency per 106 survivors at LC5o
of compound
A
Human Rodent
WI-38 Chang BHK-21 Carcinogenicity
Compound S9+ S9- S9+ S9- S9+ S9- Test Lit.
p-Dimethylaminobenzaldehyde 8 5 29 46
7,9-Dimethylbenzacridine 52 6 322 116 + +
7,10-Dimethylbenzacridine 32 6 420 128 + +
9,10-Dimethyl-1,2-benzanthracene 88 10 308 66 + ±
1,1'-Dimethyl-4,4'-bipyridinium 6 9 40 46
dichloride
3,3'-Dimethylbenzidine 28 20 296 158 + +
Dimethylcarbamoyl chloride 34 16 384 78 + ±
Dimethylformamide 12 15 46 48
Dimethylnitrosamine 86 20 308 288 + ±
2,3-Dimethylquinoxaline 9 5 76 64
Dinitrobenzene 8 5 91 80
2,4-Dinitrofluorobenzene 38 10 268 74 + +
2,4-Dinitrophenol 10 7 17 15 48 41
Dinitrosopentamethylene 6 8 68 90
tetramine
DL-Ethionine 84 12 72 70 ± ±
1,1'-Ethylene-2,2'-bipyridinium 5 5 76 66
dibromide
Ethylenethiourea 72 22 686 192 ± ±
Ethyl methanesulphonate 72 44 550 304 + +
Hexachlorocyclohexane 9 6 90 55
Hexamethylphosphoramide 54 30 366 126 ± +
Hydrazine 64 60 354 312 + +
Hydrocortisone 72 12 60 41 +
Indole 7 5 64 90
Merchlorethamine 84 80 532 408 ± +
20-Methylcholanthrene 112 14 354 192 ± +
Methylene bis(2-chloroaniline) 62 8 358 86 + +
2-Methylindole 4 3 48 82
MNNG 18 18 402 188 ± +
3-Methyl-4-nitroquinoline-N-oxide 11 15 88 52
Mitomycin C 43 10 90 38 + +
Morgan's base 11 8 286 72 + +
Naphthalene 6 4 64 74 - -
1-Naphthol 5 6 46 62 - -
2-Naphthol 6 6 33 49 -
I-Naphthylamine 7 9 41 35 - -
2-Naphthylamine 9 6 40 62 - +
2-Naphthylamine disulphonic acid 11 5 48 45 -
Nitrobenzene 8 5 48 50 -
2-Nitrobiphenyl 52 5 392 106 + +
4-Nitrobiphenyl 44 14 268 96 + ±
2-Nitrofluorene 64 14 496 158 + ±
N-Nitrosodiphenylamine 11 16 46 49
N-Nitrosoephedrine 58 5 286 44 + +
N-Nitrosofolic acid 62 8 278 69 + ±
4-Nitroquinoline-N-oxide 60 14 452 102 + +
4-Nonylphenol/ethylene oxide 11 8 46 50 -
condensate
Orotic acid 6 7 45 38 - -
Perylene 9 8 49 42 - -
Phenobarbital 6 5 40 58 -
N-phenyl-2-naphthylamine 10 5 53 65 - -
Propanesultone 52 32 240 268 ± ±
,B-Propiolactone 64 38 900 324 + ±
Resorcinol 4 6 51 38
Riboflavin 5 7 36 45
Safrole 36 38 316 78 ± +
3,3',5,5'-Tetramethylbenzidine 8 5 47 54I. P. H. PURCHASE ET AL.
TABLE 111.1.-continued.
Transformation frequency per 106 survivors at LC50
of compound
Human RodetA
Human Rodlent
Compound
Toluene
Toluene-2,4-diisocyanate
2,4,5-Trichlorophenoxyacetate
Trimethylphosphate
Urethane
Vinyl chloride*
* No toxicity observe(d.
WI-38
89+ S9-
9 4
7 6
6 8
7 7
36 8
9 9
Chang
S9+ S9-
BHK-21
S9g+ 89-
52 71
100 83
42 37
69 73
272 58
56 42
Carcinogenicity
Test Lit.
+- +
-Spontaneous Transformation
per 106 Survivors of Cell
in Transformation Assay
Transformation frequency s.d.
per 106 survivors
BHK 21-
Cl 13 WI-38 Chang
(n=30) (n=24) (n= 18)
46-7±6 4-3±0-2 7-5±2 0
46-7±7 4-8+ 1-3 9-2±2-4
50-2±7 4-7 41- 8-9±2-6
49 0±7 4-6±1-7 9-4±4-3
48-5 8 4-7±1 6 9-2±4-0
50-7±15 4-8±1-7 8-9012-7
indicate that the species or organ of
origin of the tester cells is of no signifi-
cance in this assay, and that one cell
type offers no great predictive advantage
over another. Since each cell type was
similarly effective in determining carcino-
genic potential, there seems to be little
need to use more than one cell type in the
assay.
Chang cells were used as a replacement
for W1-38 when the latter were lost. The
last 17 compounds in the study were tested
with Chang cells, including 4 compounds
previously tested with Wi-38. The use of
Chang cells did not appear to alter the
accuracy of the test and, although they
are suspected of being contaminated with
HeLa cells (Lavappa et al., 1976), very
few negative-control Chang cells were
capable of growth in semi-solid agar
(Table 111.2). Since it is difficult to prove
that compounds are non-carcinogenic, the
false-positive results may be correct.
Alternatively since the mechanism of in
vitro transformation is obscure and may be
altered from that occurring in vivo, the
false-positive results may be due to
unknown causes. It has been suggested
that the primary event in carcinogenesis
is somatic mutation (Boveri, 1914; Bauer,
1928; Burdett, 1955; Brookes and Lawley,
1964; Miller and Miller 1971; Ames et al.,
1973; Malling and Chu, 1974). However,
although many carcinogens have been
shown to react with DNA, they also react
with other cellular macromolecules and it
is not known which is the critical target in
carcinogenesis. Other observations on cell
mutation (Harris, 1974 a, b) and trans-
formation (Weinstein et at., 1975) suggest
that, while the primary event in malignant
transformation may be recessive mutation,
other changes, mutational or otherwise,
are required for a cell and its progeny to
be able to progress to a tumour.
A comparison ofthe data from mamma-
lian cell transformation with those from
bacterial mutation reveals that 106 com-
pounds are correctly identified by both
tests. Of the 14 remaining compounds 12
are identified correctly by one ofthe tests
(7 by transformation and 5 by bacterial
mutation). These results are summarized
in Table VI. It appears, therefore, that
this transformation assay, in general, is no
better than Salmonella or other bacteria
TABLE 111.2.
Frequencies
Types Used
Untreated
DMSO
S9 mix
DMSO+ 89 mix
Water
Water+S9 mix
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in detecting carcinogens. The work of
Huberman et al., (1976) and Bouck and
Di Mayorca (1976) suggests that in vitro
transformation is the result of a mutagenic
event.
Without additional metabolic activation
by rat postmitochondrial supernatant (S9
mix), very few carcinogens transformed
hamster or human cells in the period of
incubation used. It has been shown that
most carcinogens require metabolic acti-
vation, and that this may be carried out
in vitro by using liver homogenates, or
metabolically competent feeder layers of
mammalian cells, when the test cell has no
intrinsic metabolic capability (Malling,
1971; Beije and Hultin, 1971; Miller and
Miller, 1971; Garner et al., 1972; Grover et
al., 1972; Magee and Farber, 1962;
Ames et al., 1973; Huberman and Sachs,
1974; Frantz and Malling, 1975; Huber-
man, 1975).
Human cells, uninfected with virus,
have been found difficult to transform in
vitro with chemical carcinogens. Chemical
transformation of human cells has gener-
ally been of genetically abnormal or
tumorous or repair-deficient cells (Bene-
dict et al., 1975; Igel et al., 1975; Rhim et
al., 1975 a, b; Shimada et al., 1976).
However, Benedict et al. (1975), Igel et
al. (1975) and Kakunaga (1976) have
reported in vitro transformation of virally
uninfected human cells of non-tumorous
origin.
In the present study, although both the
human cell types used have a detectable
level of spontaneous transformation, few
carcinogens causedtransformation without
auxiliary metabolism by rat liver homo-
genate. The frequency of transformation
by carcinogens was, even with activation,
10-fold lower than in BHK cells. The
resistance ofhuman cells to transformation
by chemicals is possibly due to their being
less metabolically active in culture than
rodent cells, and less able to bind metabo-
lites to macromolecules (Diamond et al.,
1967; Kuroki and Heidelberger, 1972;
Marquardt and Heidelberger, 1972;
Huberman and Sachs, 1974).
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